In this activity, Dr. Pandolfino will discuss frequently asked questions on esophageal dysphagia. He will review the finer points of diagnosing dysphagia and discuss different avenues and strategies for treating and managing dysphagia in your patients.
Eosinophilic esophagitis (EoE) is a potentially serious inflammatory condition that can result in ED visits for food impaction and can severely impact quality of life for patients. Nirmala Gonsalves, MD, of Northwestern’s Fineberg School of Medicine reviews the symptoms, diagnosis, and treatment of EoE, and provides tips for long-term control of this condition.
This activity will use case-based scenarios to illustrate different patterns of liver test abnormalities. Dr. Han from the Dumont-UCLA Liver Transplant Center will discuss the difference between cholestatic versus hepatitis versus infiltrative liver diseases and their characteristic liver test patterns. Additionally, he will review the subsequent work-up of liver test abnormalities which are followed by supplemental serological testing, imaging, and in some cases, liver biopsy. He will also summarize the difference between true “liver function tests”, tests of cholestasis, tests of inflammation, and tests of infiltration.
The microbiome has been called the second human genome. It is shaped by how we were born, where we live and the foods and medicines we are given in childhood. In recent years, there has been an explosion in the number of scientific studies regarding the role of the gut microbiome in metabolic, allergic and autoimmune diseases. Therapeutic implications of altering the microbiome to alter disease states have taken shape and form an exciting new frontier of medicine.
In this activity, Dr. Hashem El-Serag, Chief of Gastroenterology and Hepatology at Baylor College of Medicine, offers clinical pearls regarding dietary considerations in the management of patients with irritable bowel syndrome.
In this activity, Dr. Lee will discuss the advantages of early screening for gastric cancer. Using a case study as an example, she will review the pros and cons of available diagnostic tests. Finally, she will discuss premalignant condition such as gastric intestinal metaplasia and its association with gastric cancer.
Dr. Leffler will address a few commonly asked questions about celiac disease. He will discuss some common issues like diagnostic tests, the right implementation of the gluten free diet and who can benefit from such a diet.
In this Clinical Coffee Break, Dr. Sanjiv Chopra answers questions collected from his live talk on the burgeoning epidemic of nonalcoholic fatty liver disease, such as how to test for fibrosis, dietary influences on hepatic fibrosis, and others.
Irritable bowel syndrome (IBS) is the most common GI disorder seen in outpatient practice. Most patients with IBS do not receive a positive IBS diagnosis. While the underlying etiology remains unclear and probably multifactorial, there has been considerable progress in the understanding of this disease. This activity will review the recent theories about IBS and discuss them in relation to diagnosis and treatment. Dr. El-Serag will also review the recent medical and psychological treatments available for IBS.
This activity will review the presenting features, diagnostic tests and management of patients with celiac disease. Dr. Leffler will discuss diagnostic problems and common issues that affect treatment and review the long term complications associated with celiac disease. He will also review available information on gluten sensitivity and discuss how the two disorders overlap.
Nonalcoholic fatty liver (NAFL) is an emerging concern among a subset of the diabetic and obese population. Complications arise when the disease progresses to nonalcoholic steatohepatitis (NASH) and cirrhosis. It is important for the primary care physician to recognize the hallmarks of NAFLD and the progression to NASH. Here, Dr. Chopra discusses strategies for diagnosis, treatment and management of patients with this hepatic disorder.